AU Patent

AU2014233577B2 — Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives

Assigned to Cassiopea SpA · Expires 2016-03-03 · 10y expired

What this patent protects

The present invention refers to an enzymatic process for obtaining 17alpha-monoesters of cortexolone and/or its 9, 5 11-dehydroderivatives starting from the corresponding 17alpha, 21-diesters which comprises an enzymatic alcoholysis reaction. Furthermore, the present invention re…

USPTO Abstract

The present invention refers to an enzymatic process for obtaining 17alpha-monoesters of cortexolone and/or its 9, 5 11-dehydroderivatives starting from the corresponding 17alpha, 21-diesters which comprises an enzymatic alcoholysis reaction. Furthermore, the present invention refers to crystalline forms of cortexolone 17alpha propionate and 9,11-dehydro-cortexolone 17alpha-butanoate. 5779166_1 (GHMatters) P82876.AU.2 PETERS 17109114

Drugs covered by this patent

Patent Metadata

Patent number
AU2014233577B2
Jurisdiction
AU
Classification
—
Expires
2016-03-03
Drug substance claim
No
Drug product claim
No
Assignee
Cassiopea SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.